Should I Buy Man Group plc?

The descent of Man Group plc (LON: EMG) has been harrowing to watch, but there have been signs of a recovery lately. Is that enough to tempt Harvey Jones?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m out shopping for shares again. Should I add Man Group (LSE: EMG) (NASDAQOTH: MGNPY.US) to my wishlist?

The descent of Man

Investors in hedge fund manager Man Group have had a rough ride in recent years, despite pocketing a mighty yield that has top 16% on occasions. Its recent interim statement included a rare piece of positive news, so is now a good time to buy it?

Man Group’s share price is down a dismal 65% over the past five years, against a 60% rise on the FTSE 100. Investors have been fleeing Man’s flagship AHL computer-traded fund in droves, following severe underperformance. Shareholders revolted last year, installing new chief executive Peter Clarke, only to boot him out six months later. He was replaced by Manny Roman, founder of hedge fund GLG, who amazingly, is still there almost one year later.

Manny is Man’s man

It was another tough start to the year for Man and Manny, as AHL continued to stumble and yet more investors headed for the exits, with outflows topping £5 billion in the first six months of 2013. Yet there was finally some good news in October, with funds under management hitting $52.5 billion in the three months to 30 September, up from $52 billion on 30 June. Man’s discretionary GLG funds produce positive performance, although this was offset by continuing falls among the AHL and FRM funds.

Slightly stronger first-half performance did attract more institutional flows into Man’s discretionary alternatives and long-only strategies, but Roman complained that recent volatility has proved challenging for hedge funds. “Despite better flows in the third quarter we remain cautious in our outlook for asset flows going forward in the light of continued uncertainty in the macro-economic environment.”

Group off

The rare glimpse of good news did help to revive the share price, up 10% in the last month to today’s 86p. If you’re an optimist, you might see this as a turning point. After years of double-digit declines, earnings per share growth is forecast to hit a healthy 38% in 2014. Don’t invest expecting a 16% yield, by the way, Man is forecast to yield just 3.9% this year rising to 5.3% next, although the actual figure will depend on the amount of surplus capital the Group can generate over that time. Better analysts than I admit they don’t understand Man Group’s business, and that alone puts me off. In February, I dismissed this stock as a speculative gamble. Nothing has changed since then. The Ascent of Man may have finally begun, but it is still too big a gamble for me.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones doesn't own shares in any company mentioned in this article

 

More on Investing Articles

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

With £1,000 to invest, should I buy growth stocks or income shares?

Dividend shares are a great source of passive income, but how close to retirement, should investors think about shifting away…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Warren Buffett should buy this flagging FTSE 100 firm!

After giving $50bn to charity, Warren Buffett still has a $132bn fortune. Also, his company has $168bn to spend, so…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing For Beginners

I wish I’d known about this lucrative style of stock market investing 20 years ago

Research has shown that over the long term, this style of investing can generate returns in excess of those provided…

Read more »

Woman using laptop and working from home
Investing Articles

Is this growing UK fintech one of the best shares to buy now?

With revenues growing at 24% and income growing at 36%, Wise looks like one of the best shares to buy…

Read more »

Dividend Shares

Are Aviva shares one of the UK’s best investments today?

UK investors have been piling into Aviva shares recently. However, Edward Sheldon's wondering if he could get bigger returns elsewhere.

Read more »

Older couple walking in park
Investing Articles

10.2% dividend yield! 2 value shares to consider for a £1,530 passive income

Royston Wild explains why investing in these value shares could provide investors with significant passive income for years to come.

Read more »

man in shirt using computer and smiling while working in the office
Investing Articles

Nvidia and a FTSE 100 fund own a 10% stake in this $8 artificial intelligence (AI) stock

Ben McPoland explores Recursion Pharmaceuticals (NASDAQ:RXRX), an up-and-coming AI firm held by Cathie Wood, Nvidia and one FTSE 100 trust.

Read more »

Electric cars charging in station
Investing Articles

Is NIO stock poised for a great rebound?

NIO stock has risen 24.5% over the past month, coming off its lows following a solid month of vehicle deliveries.…

Read more »